These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29625767)

  • 1. Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.
    Spicknall IH; Looker KJ; Gottlieb SL; Chesson HW; Schiffer JT; Elmes J; Boily MC
    Vaccine; 2019 Nov; 37(50):7396-7407. PubMed ID: 29625767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.
    Alsallaq RA; Schiffer JT; Longini IM; Wald A; Corey L; Abu-Raddad LJ
    Sex Transm Dis; 2010 May; 37(5):290-7. PubMed ID: 20351622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines.
    Schwartz EJ; Bodine EN; Blower S
    Hum Vaccin; 2007; 3(6):231-8. PubMed ID: 17881889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling study.
    Stone J; Looker KJ; Silhol R; Turner KME; Hayes R; Coetzee J; Baral S; Schwartz S; Mayaud P; Gottlieb S; Boily MC; Vickerman P
    EBioMedicine; 2023 Apr; 90():104530. PubMed ID: 36933410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.
    Gottlieb SL; Giersing B; Boily MC; Chesson H; Looker KJ; Schiffer J; Spicknall I; Hutubessy R; Broutet N;
    Vaccine; 2019 Nov; 37(50):7336-7345. PubMed ID: 28647165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine value profile for herpes simplex virus.
    Johnston C; Scheele S; Bachmann L; Boily MC; Chaiyakunapruk N; Deal C; Delany-Moretlwe S; Lee S; Looker K; Marshall C; Mello MB; Ndowa F; Gottlieb S
    Vaccine; 2024 Jul; 42(19S1):S82-S100. PubMed ID: 39003018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Schiffer JT; Gottlieb SL
    Vaccine; 2019 Nov; 37(50):7363-7371. PubMed ID: 28958807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.
    Schwartz EJ; Blower S
    J Infect Dis; 2005 May; 191(10):1734-46. PubMed ID: 15838802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential epidemiological impact of a genital herpes vaccine for women.
    Garnett GP; Dubin G; Slaoui M; Darcis T
    Sex Transm Infect; 2004 Feb; 80(1):24-9. PubMed ID: 14755031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
    Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
    Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV-2: in pursuit of a vaccine.
    Johnston C; Koelle DM; Wald A
    J Clin Invest; 2011 Dec; 121(12):4600-9. PubMed ID: 22133885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
    Garnett GP
    J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Gottlieb SL; Giersing BK; Hickling J; Jones R; Deal C; Kaslow DC;
    Vaccine; 2019 Nov; 37(50):7408-7418. PubMed ID: 29224963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological impact of a genital herpes type 2 vaccine for young females.
    Lou Y; Qesmi R; Wang Q; Steben M; Wu J; Heffernan JM
    PLoS One; 2012; 7(10):e46027. PubMed ID: 23071536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data.
    Looker KJ; Welton NJ; Sabin KM; Dalal S; Vickerman P; Turner KME; Boily MC; Gottlieb SL
    Lancet Infect Dis; 2020 Feb; 20(2):240-249. PubMed ID: 31753763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.
    Behling J; Chan AK; Zeh C; Nekesa C; Heinzerling L
    PLoS One; 2015; 10(5):e0128370. PubMed ID: 26010772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital herpes vaccines--cause for cautious optimism.
    Haddow LJ; Mindel A
    Sex Health; 2006 Mar; 3(1):1-4. PubMed ID: 16607967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
    Marrazzo JM; Rabe L; Kelly C; Richardson B; Deal C; Schwartz JL; Chirenje ZM; Piper J; Morrow RA; Hendrix CW; Marzinke MA; Hillier SL;
    J Infect Dis; 2019 May; 219(12):1940-1947. PubMed ID: 30753642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and herpes simplex virus type 2 epidemiological synergy: misguided observational evidence? A modelling study.
    Omori R; Nagelkerke N; Abu-Raddad LJ
    Sex Transm Infect; 2018 Aug; 94(5):372-376. PubMed ID: 29203577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.